Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
26%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
CANC
52
HOLDINGS
23%
ALSO IN IDNA
IDNA
44
HOLDINGS
32%
ALSO IN CANC
SECTOR DRIFT (CANC minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | 7.5% | 6.1% | 6.1% | |
| ASTRAZENECA PLC | 4.0% | 4.1% | 4.0% | |
| EXELIXIS INC | 2.8% | 3.3% | 2.8% | |
| CELCUITY INC. | 2.6% | 5.7% | 2.6% | |
| ARCELLX, INC. | 2.4% | 3.4% | 2.4% | |
CANC Overweight Relative to IDNA
| ELI LILLY & CO | 5.8% | |
| BRIDGEBIO PHARMA, INC. | 4.4% | |
| ROCHE HOLDINGS LTD-SPONS ADR | 4.0% | |
| COGENT BIOSCIENCES INC | 3.9% | |
| GENMAB A/S SPONSORED ADR | 3.8% | |
| NOVARTIS AG | 3.5% | |
| NUVALENT, INC. CLASS A | 3.4% | |
| IDEAYA BIOSCIENCES, INC. | 2.7% | |
| JOHNSON & JOHNSON | 2.5% | |
| ABBVIE INC | 2.4% |
CANC Underweight Relative to IDNA
| INCYTE CORP | -4.9% | |
| GENMAB A/S | -4.6% | |
| ROCHE HOLDING LTD | -3.8% | |
| GSK PLC | -3.7% | |
| REGENERON PHARMACEUTICALS | -3.7% | |
| TWIST BIOSCIENCE CORP. | -3.3% | |
| SANOFI-AVENTIS | -3.2% | |
| TAKEDA PHARMACEUTICAL CO LTD | -3.1% | |
| BIONTECH SE SPONSORED ADR | -3.1% | |
| CELCUITY INC. | -3.1% |